FDA Approved: AYVAKIT — Supplemental Application (Blueprint Medicines Corporation)

View source ↗

Summary

FDA approved a supplemental application for AYVAKIT (avapritinib) from Blueprint Medicines Corporation to update the product label (including potential new indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor
• Systemic Mastocytosis

Drugs mentioned

• AYVAKIT (avapritinib)

Snippet

SUPPL AP for AYVAKIT (AVAPRITINIB)